APAC Leukaemia Therapeutics Market, Market Segmented, by Disease Condition (Chronic Lymphatic Leukaemia, Acute Lymphatic Leukaemia, Chronic Myeloid Leukaemia, and Acute Myeloid Leukaemia), by Diagnosis (CT scan, Biopsy, and MRI), by Treatments (Chemotherapy, Radiation therapy, Immunotherapy, Surgery, Targeted Therapy, Bone marrow transplant, and Stem Cell Therapy), and by Drugs (Gleevec, Sapacitabine, GA101, Vasaroxine, and Tosedosat)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138310
- Pages: 200
-
Format:
Report Overview
The APAC Leukemia Therapeutics Market, market size stood at around USD $1.47 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Leukemia is the cancer of the white blood cells or the bone marrow, which occurs due to an abnormal increase in the count of white blood cells. There are several types of leukemia that appear suddenly and progress rapidly over days to weeks. It can be identified by the spread of the diseases and by the type of the blood cell that is affected
Market Drivers
The market for Leukemia Therapeutics in Asia-Pacific region is mainly driven due to factors like increasing aging population due to which there is an increasing occurrence of leukemia, along with increasing awareness of patients regarding most recent technological developments
1. APAC Leukaemia Therapeutics Market Overview
A. Market Size
2. APAC Leukaemia Therapeutics Growth Drivers and Restraints
A. Increasing aging population due to which there is an increasing occurrence of leukaemia
B. Increasing awareness of patients regarding most recent technological developments
3. APAC Leukaemia Therapeutics Market Segmentation
A. By Disease Condition
I. Chronic Lymphatic Leukaemia
II. Acute Lymphatic Leukaemia
III. Chronic Myeloid Leukaemia
IV. Acute Myeloid Leukaemia
B. By Diagnosis
I. CT scan
II. Biopsy
III. MRI
C. By Treatment
I. Chemotherapy
II. Radiation therapy
III. Immunotherapy
IV. Surgery
V. Targeted Therapy
VI. Bone marrow transplant
VII. Stem Cell Therapy
D. By Drugs
I. Gleevec
II. Sapacitabine
III. GA101
IV. Vasaroxine,
V. Tosedosat
4. Leukaemia Therapeutics Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. AstraZeneca PLC, Company overview, Product & Services, Strategies & Financials
B. Bayer AG, Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline PLC, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
